Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ubiquitin specific peptidase 1 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Hypothetical protein | 0.0141 | 0.8746 | 0.8746 |
Leishmania major | silent information regulator 2, putative | 0.0141 | 0.8746 | 1 |
Plasmodium falciparum | transcriptional regulatory protein sir2a | 0.0082 | 0.3233 | 1 |
Mycobacterium ulcerans | NAD-dependent deacetylase | 0.0082 | 0.3233 | 1 |
Schistosoma mansoni | chromatin regulatory protein sir2 | 0.0154 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0106 | 0.5459 | 0.5459 |
Echinococcus granulosus | NAD dependent deacetylase sirtuin 1 | 0.0154 | 1 | 1 |
Giardia lamblia | NAD-dependent histone deacetylase Sir2 | 0.0154 | 1 | 1 |
Plasmodium vivax | NAD-dependent deacetylase, putative | 0.0082 | 0.3233 | 1 |
Echinococcus multilocularis | NAD dependent deacetylase sirtuin 1 | 0.0154 | 1 | 1 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.0154 | 1 | 1 |
Trypanosoma brucei | Silent information regulator 2 related protein 3 | 0.0082 | 0.3233 | 0.3696 |
Schistosoma mansoni | chromatin regulatory protein sir2 | 0.0141 | 0.8746 | 0.8746 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.0141 | 0.8746 | 0.8746 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.0082 | 0.3233 | 0.3233 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.0082 | 0.3233 | 0.3233 |
Leishmania major | NAD dependent deacetylase, putative,transcriptional regulator, Sir2 family protein, nicotinic acid mononucleotide 5,6-dimethylbe | 0.0082 | 0.3233 | 0.3696 |
Trypanosoma brucei | Silent information regulator 2 related protein 1 | 0.0141 | 0.8746 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0154 | 1 | 1 |
Entamoeba histolytica | Sir2 family transcriptional regulator, putative | 0.0141 | 0.8746 | 1 |
Toxoplasma gondii | histone deacetylase SIR2 | 0.0082 | 0.3233 | 1 |
Schistosoma mansoni | chromatin regulatory protein sir2 | 0.0082 | 0.3233 | 0.3233 |
Mycobacterium tuberculosis | Transcriptional regulatory protein | 0.0082 | 0.3233 | 0.5 |
Giardia lamblia | Transcriptional regulator, Sir2 family | 0.0082 | 0.3233 | 0.3233 |
Echinococcus multilocularis | chromatin regulatory protein sir2 | 0.0141 | 0.8746 | 0.8746 |
Trypanosoma cruzi | Silent information regulator 2 related protein 1 | 0.0141 | 0.8746 | 1 |
Loa Loa (eye worm) | transcriptional regulator | 0.0141 | 0.8746 | 0.8746 |
Echinococcus granulosus | chromatin regulatory protein sir2 | 0.0141 | 0.8746 | 0.8746 |
Brugia malayi | transcriptional regulator, Sir2 family protein | 0.0141 | 0.8746 | 0.8746 |
Trypanosoma cruzi | Silent information regulator 2 related protein 1 | 0.0141 | 0.8746 | 1 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.0141 | 0.8746 | 0.8746 |
Entamoeba histolytica | Sir2 family transcriptional regulator, putative | 0.0082 | 0.3233 | 0.3696 |
Entamoeba histolytica | Sir2 family transcriptional regulator, putative | 0.0141 | 0.8746 | 1 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.0154 | 1 | 1 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.0154 | 1 | 1 |
Schistosoma mansoni | chromatin regulatory protein sir2 | 0.0141 | 0.8746 | 0.8746 |
Echinococcus multilocularis | NAD dependent deacetylase sirtuin 3 | 0.0141 | 0.8746 | 0.8746 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.0082 | 0.3233 | 0.3233 |
Schistosoma mansoni | chromatin regulatory protein sir2 | 0.0141 | 0.8746 | 0.8746 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.0154 | 1 | 1 |
Echinococcus granulosus | NAD dependent deacetylase sirtuin 3 | 0.0141 | 0.8746 | 0.8746 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 5.0119 uM | PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.